{"version":"1.0","type":"link","title":"Real-World Safety Profile of Ibrutinib in Chronic Lymphocytic Leukemia: A Focus on Adverse Events, Discontinuations, and Effectiveness Outcomes.","author_name":"Martínez Pradeda A 외","author_url":"https://prs-insight.online/author/Mart%C3%ADnez%20Pradeda%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/164219","thumbnail_width":1200,"thumbnail_height":630}